Compounded Semaglutide vs Wegovy (2026): Cost and Key Differences
Quick Answer: Compounded semaglutide or Wegovy — what's the real difference?
Wegovy is the FDA-approved semaglutide product; compounded semaglutide is a pharmacy-prepared medication made to an individual prescription and is not FDA-approved. The practical trade-off in 2026: self-pay Wegovy runs $149–$349/month through NovoCare (more through most telehealth platforms), while compounded programs typically run $99–$175/month all-in. If insurance covers Wegovy, take Wegovy. If you're paying cash, compare total monthly cost at your maintenance dose — not the advertised starter price.
What Each One Actually Is
Wegovy is Novo Nordisk's brand-name semaglutide injection (now also available as a daily pill), FDA-approved for chronic weight management. Approval means the product's manufacturing, dosing, labeling, and clinical evidence — including the STEP trials, where participants lost roughly 15% of body weight on average over 68 weeks alongside diet and exercise — were reviewed by the FDA.
Compounded semaglutide is prepared by a licensed US compounding pharmacy for an individual patient, pursuant to a prescription from a licensed provider. Compounded medications are not FDA-approved: the final product doesn't go through FDA review for safety, effectiveness, or manufacturing quality, and its formulation may differ from the commercial product. Quality rests on the dispensing pharmacy's licensing and state regulation — which is why "which pharmacy?" is a fair question to ask any program.
In 2025 the FDA declared the semaglutide shortage resolved, ending the era of mass-market compounded copies. Hims settled with Novo Nordisk and wound down compounded semaglutide for new patients; Ro moved to brand-name only. Compounding continues where it always was permitted: patient-specific prescriptions filled by licensed pharmacies. That's the model smaller platforms, including FitFlowRx, operate under today.
What Each Costs Without Insurance (August 2026)
| Route | Typical self-pay price | Notes |
|---|---|---|
| Wegovy via NovoCare (manufacturer direct) | $149/mo (pill, lower doses) to $349/mo (pen, standard doses) | Promotional intro pricing on starter doses; price steps up with dose |
| Wegovy via Hims / Ro | $149–$399/mo medication | Plus $149/mo membership ($39 first month) at both |
| Compounded semaglutide via telehealth | Roughly $99–$250/mo depending on platform | FitFlowRx: $99–$175/mo all-in, flat at every dose. Not FDA-approved |
Sources: novocare.com, hims.com, ro.co, and fitflowrx.com public pricing pages, August 2026. All of these change frequently — verify before you buy. See our full semaglutide cost guide for the insurance picture.
The detail most shoppers miss: dose titration changes the math. Semaglutide is started low and increased over several months to a maintenance dose. Brand-name self-pay prices typically step up as the dose does, while some compounded programs (including ours) charge the same flat price at every dose. Compare prices at the dose you'll actually be maintained on, not the month-one teaser.
When Wegovy Is the Right Answer
- Your insurance covers it. A covered brand-name product with FDA oversight at a $25–$50 copay beats any cash-pay option.
- You want FDA-reviewed manufacturing and labeling and the price difference isn't decisive for you.
- Your provider recommends it based on your history — some patients have clinical reasons to prefer the approved product.
And when cash price is the deciding factor, a compounded program from a platform that publishes its pharmacy sourcing, screens every intake through licensed providers, and holds LegitScript certification is the comparison to make. Ours is here, priced at $99–$175/month.
Side Effects Don't Care Which You Choose
Nausea, vomiting, diarrhea, and constipation are the most common side effects of semaglutide in any form, especially during dose increases. It should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, or during pregnancy. Both routes require provider screening — our guide to GLP-1 eligibility covers who qualifies and who shouldn't take these medications.
Frequently Asked Questions
Is compounded semaglutide the same as Wegovy?
No. Wegovy is Novo Nordisk's FDA-approved semaglutide product, manufactured and reviewed under FDA oversight. Compounded semaglutide is prepared by licensed US compounding pharmacies pursuant to an individual provider's prescription. The compounded final product is not FDA-approved, and its formulation may differ from the commercial product.
How much cheaper is compounded semaglutide than Wegovy?
As of August 2026, self-pay Wegovy through NovoCare runs $149–$349/month depending on form and dose, and $199–$399+ through platforms like Hims and Ro before their $149/month membership fees. Compounded semaglutide programs on telehealth platforms typically run $99–$175/month all-in. The gap widens at higher maintenance doses, where brand-name prices step up but flat-priced compounded programs don't.
Why is compounded semaglutide still available after the FDA shortage ended?
When the FDA declared the semaglutide shortage resolved in 2025, mass compounding of copies wound down, and large platforms like Hims and Ro exited. Licensed compounding pharmacies may still prepare medications for an individual patient when a licensed provider writes a prescription for a clinically appropriate, patient-specific formulation. That is the basis on which smaller telehealth programs continue to operate.
Is Wegovy safer than compounded semaglutide?
Wegovy has FDA-reviewed manufacturing, labeling, and clinical trial data behind it — that oversight is the core advantage of a brand-name product, and if insurance covers it, it's often the sensible choice. Compounded medications do not undergo FDA review; quality depends on the dispensing pharmacy, which is why it matters that the pharmacy is US-licensed and state-regulated. Both routes require a prescription and provider screening, and both carry the same class side effects.
This article is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any weight loss medication. FitFlow is a telehealth platform and does not manufacture or compound medications. Compounded medications are prepared and dispensed by licensed U.S. compounding pharmacies pursuant to a prescription from a licensed provider; compounded drugs are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. FitFlowRx is not affiliated with Novo Nordisk, Hims, or Ro.
See if you qualify
Compounded semaglutide from $99/mo, all-in — consultation, medication if prescribed, and shipping included. Flat price at every dose.